Home Authors Articles by David Orchard-Webb, PhD

David Orchard-Webb, PhD

477 ARTICLES 0 COMMENTS
David is a consultant/medical writer for a number of ongoing healthcare initiatives including for Athla LLC/ HealthLabs, a discovery automation company for Big Data leveraging Big Compute. He has a number of years experience in academic R&D and healthcare related projects including the fields of oncology and immunotherapy.

AmnioFix® Injectable Granted RMAT Designation By The FDA For The Treatment Of Osteoarthritis Of...

MiMedx Group, Inc. developed the proprietary PURION® Process that separates placental tissues collected after birth, cleans and reassembles layers, and then dehydrates the tissue for long term storage under sterile conditions. The PURION® Process removes free blood while retaining...

BioLife Solutions’ CryoStor® Cell Freeze Media Evaluated In A PDX Banking Study

Xenografts using cancer cell lines in immunocompromised animal models have been used in research for many years, however there are concerns that these models do not adequately reflect the heterogeneity of an actual patient tumour. To overcome this patient-derived...

Humacyte Funding Will Support Final Stage Clinical Development Of Its Regenerative Medicine

Humacyte, Inc., is a privately held clinical stage biotechnology company developing the technology of human acellular vessels (HAVs). It is a type of bioengineered vein. HAVs are produced in a cell culture bioreactor and then acellularized. Proposed uses include...

STEMCELL Technologies Licenses Inner Ear Organoid Culture Technique

The ability to hear music and keep balanced when upright is dependent on mechanosensory “hair cells” in the inner ear that convert vibrations into electrical signals . They are located inside the organ of Corti within the snail-shaped cochlea...

Exclusive Strategic Business Partnership – Trans-Hit Bio And Q&T Research

Trans-Hit Bio based in Laval, Quebec, a worldwide biospecimen access contract research organisation (CRO), has entered into a strategic partnership with Q&T Research Sherbrooke Inc. - a dedicated research center investigating multiple therapeutics that has been operating since 1994...

Sigilon Therapeutics’ Lead Cell Therapy Product Granted ATMP Designation By EMA

Sigilon Therapeutics is an early stage (preclinical) biotechnology company developing an encapsulated cell therapy technology. Its Afibromer™ Living Therapeutic candidate SIG-003 has been granted an Advanced Therapy Medicinal Product (ATMP) designation by the Committee for Advanced Therapies of the...

WuXi NextCODE And Google Cloud Partner

WuXi NextCODE a fully integrated contract genomics organization (CGO) has partnered with Google Cloud to deliver comprehensive genomics capabilities to partners and customers worldwide . Both Genomics England and the Sidra Medical and Research Center for the genomics and...

New Insight Into The FTO Gene And Obesity Risk Made Possible By FitnessGenes Customers

FitnessGenes Ltd. is a DNA-testing company offering fitness and nutrition guidance. With an in-mail spit collection DNA kit and in-house analysis of 41 gene variations, that reveal specific personal traits including metabolic tendencies, dietary sensitivities, fat burning capacity, muscle...

BioDuro Acquires Molecular Response Cancer Biobank And Biorepository

BioDuro LLC is a global life sciences contract research and development organization (CRO). The company has acquired Molecular Response LLC and its extensive cancer biobank of >100,000 viable tumors, as well as its capacity as a biorepository. Molecular Response...

The PURA Syndrome Biobank – An International Resource

The PURA gene is located at chromosome 5, band q31 . It encodes the Pur alpha (PurA) protein which is a sequence-specific single-stranded-DNA-binding protein that is known to be particularly important for brain development. For example, lack of PurA...

🔥 Most Popular



Featured Vendors
X